These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. Kind AH; Zakowski LJ; McBride PE WMJ; 2002; 101(7):53-6. PubMed ID: 12426921 [TBL] [Abstract][Full Text] [Related]
10. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
11. Diabetic Dyslipidemia: Epidemiology and Prevention of Cardiovascular Disease and Implications of Newer Therapies. Warraich HJ; Rana JS Curr Cardiol Rep; 2018 Oct; 20(12):125. PubMed ID: 30311078 [TBL] [Abstract][Full Text] [Related]
12. Managing the underestimated risk of statin-associated myopathy. Rallidis LS; Fountoulaki K; Anastasiou-Nana M Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193 [TBL] [Abstract][Full Text] [Related]
13. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy. Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165 [TBL] [Abstract][Full Text] [Related]
15. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study. Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the drug-drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies. Schwier NC; Cornelio CK; Boylan PM Pharmacotherapy; 2022 Apr; 42(4):320-333. PubMed ID: 35175631 [TBL] [Abstract][Full Text] [Related]
17. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Harper CR; Jacobson TA Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Kostapanos MS; Milionis HJ; Elisaf MS Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931 [TBL] [Abstract][Full Text] [Related]
19. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil]. Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824 [TBL] [Abstract][Full Text] [Related]